FY constant currency adjusted revenue in the 1-3% range (previously ‘around the lower end of the 3-5% range’)
Mid-Single Figure FY constant currency adjusted diluted EPS growth (previously ‘High-Single Figure’)
Continued deleveraging of the balance sheet to around 3x Adjusted Net Debt to Adjusted EBITDA by end 2021, (previously ‘below 3x’), given the impact of COVID-19 on our operating results in 2020
A continued dividend pay-out ratio of 65% of adjusted diluted EPS and growth in sterling terms, supported by a strong liquidity position
https://www.bat.com/group/sites/UK__9D9 ... e/DOBQDL9W
RNS here; https://www.investegate.co.uk/british-a ... 00023229P/
BATS are my tobacco share of choice for my HYP. I've topped up twice this year, and they form 5.5% in capital value terms of my HYP. The comment regarding the dividend is reassuring, particularly in these times.
Ian.